The home healthcare market size is projected to reach US$ 587.00 billion by 2031 from US$ 332.33 billion in 2024. The market is expected to register a CAGR of 8.5% during 2025–2031. The adoption of advanced technologies in homecare settings is likely to bring in new market trends during the forecast period.
Elderly individuals are more likely to suffer from chronic health issues, including heart disease, diabetes, hypertension, arthritis, and respiratory ailments. Home healthcare is essential for managing such chronic diseases by offering skilled nursing care, patient education, and training. For example, nurses can educate patients living with hypertension on how to monitor their blood pressure levels or help diabetic patients learn to use blood glucose meters. Home healthcare is more cost-effective than hospital care and minimizes the risk of healthcare-associated infections. It also promotes aging in place and fosters independence, which are crucial for ensuring a good quality of life for older adults.
With the global population aging, governments across the globe are acknowledging the significance of delivering comprehensive healthcare services to senior citizens, which includes care within the home. This awareness is leading to various initiatives and programs focused on enhancing the quality of life for older adults and encouraging healthy aging. For instance, in September 2024, the Centers for Medicare & Medicaid Services (CMS) published a report detailing the agency's analysis of the Acute Hospital Treatment at Home (AHCAH) program, which permits some Medicare-certified hospitals to provide inpatient-level treatment to patients at their homes. The Consolidated Appropriations Act (CAA), 2023, extended the waivers and flexibilities related to the AHCAH project until December 31, 2024, although the program was started under the COVID-19 public health emergency (PHE). Such initiatives benefit the well-being of seniors and increase the demand for home healthcare services.
The growth of the market in the Asia Pacific region is owing to the growing prevalence of chronic disorders, increasing product approvals, increasing number of market players, developing healthcare infrastructure, and rising investments to bolster healthcare facilities. Increasing consumption of alcohol, obesity, lack of physical activity, and excess saturated fats in the diet are contributing to the growing prevalence of noncommunicable diseases (NCDs) such as heart disease, stroke, diabetes, cancers, and chronic respiratory diseases. As per the Centers for Disease Control and Prevention (CDC), approximately 82% of China’s disease burden is due to NCDs. In China, there are high levels of salt intake and tobacco use, which greatly increase the risk of heart attacks and stroke. In China, in 2020, there were 3.4 million new cases, 17.8 million prevalent cases, and 2.3 million deaths due to stroke. As per the Globocan 2022 report, lung cancer is the most common cancer in China. There were 1,060,584 cases of lung cancer in China in 2022. Thus, the growing prevalence of chronic diseases is likely to increase the demand for home healthcare services in China.
Home healthcare is a more affordable option than standard inpatient facilities such as nursing homes and hospitals. According to Partnership for Quality Home Healthcare, a 30-day stay in a skilled nursing facility costs nearly US$ 16,500, while home healthcare costs ~US$ 2,010 for the same duration. Reduced rates of emergency room (ER) visits, readmissions, and hospital hospitalizations among patients receiving home-based care further increase these savings by preventing expensive and preventable accidents. As per the Partnership for Quality Home Healthcare, through its Home Health Value-Based Purchasing (HHVBP) Model, Medicare has saved nearly US$ 1.38 billion over six years in just nine states in the US. According to the Commonwealth Funds, when compared to typical hospital care, "hospital at home" programs have shown comparable outcomes and fewer problems at a cost of at least 30% less. Such programs are well established in countries such as England, Canada, and Israel, where payment policies encourage the provision of health care services in less costly venues. Thus, the cost-effectiveness of home healthcare services, coupled with increasing developments by the market players, contributes to the growing demand for these services.
Government initiatives such as "National Programme for the Health Care of Elderly" (NPHCE) since 2010 prioritize the provision of primary, secondary, and tertiary healthcare facilities for people over 60. The scope of this program has been extended to geriatric primary and secondary care services, such as lab, physiotherapy, IPD, and OPD, across 713 health districts in India. Such initiatives benefit the well-being of seniors and increase the demand for home healthcare services. Government support also extends to financial assistance and insurance coverage for home healthcare services. In the United States, Medicaid and Medicare provide federal coverage for these services, while state-specific coverage varies. These government-funded initiatives increase the accessibility and affordability of home healthcare, which encourages older people and those with long-term illnesses to use it. Governments are also enforcing laws and quality control procedures to guarantee the efficacy and safety of home healthcare services. Better, intelligent, and healthier healthcare delivery is the main goal of the US Centers for Medicare & Medicaid Services' (CMS) Quality Strategy. Therefore, government initiatives to encourage the adoption of home healthcare services are expected to create opportunities for the service providers to expand their offerings and gain market share during the forecast period.
Key segments that contributed to the derivation of the home healthcare market analysis are type, service, and indication.
The geographical scope of the home healthcare market report mainly focuses on five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the global market in 2024 and is expected to continue its dominance during the forecast period. The US is the largest market for home healthcare in the world. The growth of the home healthcare market in the US is driven by the increasing adoption of advanced medical device technologies, growing digitalization of medical devices, increasing emphasis on improving treatment outcomes, and increasing prevalence of chronic diseases. Chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the US. As per the US Department of Health and Human Services, an estimated 129 million people in the US have at least one major chronic disease. As per the Centers for Disease Control and Prevention (CDC) 2024, chronic and mental diseases cost US$ 4.5 trillion in annual health care costs. Also, the increasing penetration of home healthcare services across the country is driving its adoption. For instance, in November 2024, Internal Healthcare Group, a new senior referral service, launched a virtual service to help connect seniors and families with quality care providers. Serving the US and Australia, they specialize in finding home health agencies, assisted living, independent living, and senior day centers that fit individual needs and budgets. In April 2024, the Food and Drug Administration (FDA) announced the launch of the Home as a Health Care Hub, a new initiative created to advance healthcare-at-home in the US and improve health equity.
The regional trends and factors influencing the Home Healthcare Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Home Healthcare Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 332.33 Billion |
| Market Size by 2031 | US$ 587.00 Billion |
| Global CAGR (2025 - 2031) | 8.5% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Service
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Home Healthcare Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Home Healthcare Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The home healthcare market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. Below are a few of the key developments witnessed in the home healthcare market:
The "Home Healthcare Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
The List of Companies - Home Healthcare Market
The surging prevalence of chronic diseases among the aging population and the cost-effectiveness of home healthcare services are among the significant factors fueling the market growth.
The adoption of advanced technologies in homecare settings is likely to emerge as a new growth trend in the market in the coming years.
Enhabit Home Health & Hospice, Apollo HomeCare, Cura Mexico, Koninklijke Philips NV, LHC Group Inc, BAYADA Home Health Care, Mears Group Plc, Abbott Care, Amedisys Inc, Kindred Healthcare, LLC, and CenterWell Home Health are among the key players operating in the market.
The home healthcare market value is expected to reach US$ 587.00 billion by 2031.
North America dominated the market in 2024.
The market is expected to register a CAGR of 8.5% during 2024–2031.